Table 3.
Pseudomonas aeruginosa serotype distribution by each investigator site
| Investigator site | O1 | O2 | O6 | O10 | O11 | PL5 | NT | Total | |
|---|---|---|---|---|---|---|---|---|---|
| 1 | n | 2 | 0 | 8 | 2 | 1 | 2 | 1 | 16 |
| % | 12.5% | 0.0% | 50.0% | 12.5% | 6.3% | 12.5% | 6.3% | 100% | |
| 2 | n | 1 | 0 | 3 | 2 | 2 | 3 | 2 | 13 |
| % | 7.7% | 0.0% | 23.1% | 15.4% | 15.4% | 23.1% | 15.4% | 100% | |
| 3 | n | 2 | 4 | 12 | 1 | 14 | 4 | 3 | 40 |
| % | 5.0% | 10.0% | 30.0% | 2.5% | 35.0% | 10.0% | 7.5% | 100% | |
| 4 | n | 0 | 0 | 3 | 1 | 3 | 1 | 2 | 10 |
| % | 0.0% | 0.0% | 30.0% | 10.0% | 30.0% | 10.0% | 20.0% | 100% | |
| 5 | n | 1 | 1 | 5 | 0 | 1 | 2 | 0 | 10 |
| % | 10.0% | 10.0% | 50.0% | 0.0% | 10.0% | 20.0% | 0.0% | 100% | |
| 6 | n | 4 | 5 | 4 | 1 | 2 | 2 | 0 | 18 |
| % | 22.2% | 27.8% | 22.2% | 5.6% | 11.1% | 11.1% | 0.0% | 100% | |
| 7 | n | 0 | 1 | 1 | 5 | 1 | 2 | 2 | 12 |
| % | 0.0% | 8.3% | 8.3% | 41.7% | 8.3% | 16.7% | 16.7% | 100% | |
Investigator sites with more than 10 patients were analyzed. Percentages of serotype are expressed in boldface. NT, not typeable; PL5, sum of all serotypes with a prevalence of less than 5%.